'Fidgety' babies of diabetic moms don't get large

Key points
- Pregnant women with diabetes tend to have abnormally large babies, but it seems that active fetuses manage to stay a relatively normal size, new research suggests.
- While babies of diabetic women are prone to become overly big, a condition called macrosomia, it has been unclear why a substantial proportion do not develop this problem.
- As reported in the medical journal Diabetes Care, Dr.
- In the first phase, involving 10 women, the researchers showed that fetal movements are pretty consistent from one day to the next.
Pregnant women with diabetes tend to have abnormally large babies, but it seems that active fetuses manage to stay a relatively normal size, new research suggests.
While babies of diabetic women are prone to become overly big, a condition called macrosomia, it has been unclear why a substantial proportion do not develop this problem. The "fidgety fetus hypothesis" has been proposed as an explanation, suggesting that increased fetal activity can counteract the macrosomia-promoting effects of the mother's high glucose levels.
As reported in the medical journal Diabetes Care, Dr. Lois Jovanovic, from Sansum Diabetes Research Institute in Santa Barbara, California, and colleagues tested this notion in a three-phase study involving 69 women with gestational diabetes.
In the first phase, involving 10 women, the researchers showed that fetal movements are pretty consistent from one day to the next.
The second phase, which included 13 women and involved the use of a home fetal monitoring device, showed that active fetuses, defined as having at least 4 heart rate accelerations in a 20-minute period, are always active, while inactive fetuses are always inactive.
Finally, in the third and largest phase, involving 46 mothers, the researchers showed that the average birth weight of the active fetuses was in the 37th percentile, significantly lower than the 62 percentile for inactive fetuses. Macrosomia is typically defined as a birth weight heavier than the 90th percentile for gestational age.
"The fetus appears to play a role in determining its own destiny," Jovanovic and colleagues write.
They conclude: "Although normoglycemia is the goal of therapy in all women with diabetes, in those women whose fetuses manifest less movement, increased surveillance and treatment of hyperglycemia is of utmost importance."
SOURCE: Diabetes Care, January 2006.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Diabetes & Hormones →
NewsBody mass index may predict heart disease risk for type-2 diabetic patients new study finds
Researchers from the Intermountain Medical Center Heart Institute, in collaboration with researchers from Johns Hopkins University and the National Institutes of Health, have discovered a simple way to further predict a…
18 November 2013
News'Diabetic flies' can speed up disease-fighting research
In a finding that has the potential to significantly speed up diabetes research, scientists at the University of Maryland have discovered that fruit flies respond to insulin at the cellular level much like humans do,…
8 November 2013
NewsEnzyme restores function with diabetic kidney disease
Researchers at the University of California, San Diego School of Medicine say that, while a prevailing theory suggests elevated cellular levels of glucose ultimately result in diabetic kidney disease, the truth may, in…




